Initially, when vaccines were deployed with Messenger RNA (mRNA) encapsulated in lipid nanoparticles (LNPs), researchers thought it remained near the injection site and quickly degraded.
However, recent reports published by well-known clinical journals suggest that the mRNA/LNPs can enter the bloodstream, accumulate in tissues, and may be passed to infants in expressed breast milk (EBM).
To better understand how this occurrence may impact infants, a leading journal published a study supported by the Department of Pediatrics, NYU-Grossman Long Island School of Medicine.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
